Staar Surgical (STAA) shares catapulted into a profit-taking zone Thursday after the eye surgery outlet obliterated first-quarter profit expectations.
The company, which makes implantable ocular lenses and other tools for ophthalmic surgery, put up adjusted earnings of 41 cents per share
Not only did earnings flip from a year-earlier loss of 52 cents a share, they also walloped forecasts for… Related news Staar Surgical Stock Earns RS Rating Upgrade 6/27/2024 Staar Surgical shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 87. 6/27/2024 Staar Surgical shows rising price performance, earning an upgrade to